We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Coagulation Test Correlates Protein Concentration for Plasma Cell Dyscrasia

By LabMedica International staff writers
Posted on 07 Jan 2013
Abnormal screening coagulation tests are frequently observed in asymptomatic patients with multiple myeloma and other plasma cell neoplasms. More...


Prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen activity have been linked with clinical history and disease parameters in patients with plasma cell dyscrasia.

Scientists at the University of Arkansas for Medical Sciences (Little Rock, AR, USA) studied coagulation tests in a total of 252 patients. Of these, 79 patients (31%) had abnormal routine screening coagulation test results. An isolated prolonged PT of greater than 15 seconds was found in 62 patients (25%), and 10 patients had prolonged PT and APTT (4%).

Prothrombin time, APTT, and fibrinogen activity were analyzed on the STA-R Evolution, using PT reagent Neoplastine CI PLUS and APTT reagent STA-PTT A, all products of Diagnostica Stago (Parsippany, NJ, USA). Fibrinogen activity was determined by measuring the clotting time of diluted plasma in the presence of excess thrombin with a reference range of 197–447 mg/dL. The quantitation of monoclonal proteins was performed by separating serum proteins using capillary electrophoresis with direct protein detection by UV absorbance at 200 nm.

An isolated prolonged PT was the most common abnormal coagulation test found in 25% of the patients. A prolonged PT was more frequently observed in 157patients with the multiple myeloma compared to the 34 monoclonal gammopathy of undetermined significance (MGUS) patients or other diagnostic categories of plasma cell dyscrasia. There were no differences immunoglobulin isotype in 62 patients with isolated prolonged PT compared to the 173 patients with normal screening coagulation tests. Fibrinogen activity was significantly lower in patients with prolonged PT although there was no correlation between fibrinogen activity and PT. Serum M protein concentrations were significantly greater in patients with prolonged PT and were positively correlated with PT. Serum M protein concentrations were significantly elevated in patients with prolonged PT compared to patients with normal PT and were positively correlated with PT values.

The authors concluded that there was an association between disease severity and prolonged PT in that patients with multiple myeloma were more likely to have prolonged PT than patients with other plasma cell neoplasms. Of the factors examined, the monoclonal protein level was significantly higher in patients with isolated prolonged PT and correlated with PT. The study was published on December 7, 2012, in the International Journal of Laboratory Hematology.

Related Links:
University of Arkansas for Medical Sciences
Diagnostica Stago


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.